| 31.27 Data as of Jun 19 | -0.60 / -1.88%Today’s Change | 20.50 Today|||52-Week Range 32.27 | +13.92% Year-to-Date |
| Mylan Announces Pricing of $1.15B in Senior Notes; Refinancing Revolving Credit Facil... Jun 18 / Benzinga | Warner Chilcott: Should You Buy Joel Greenblatt's Latest Pick? Jun 13 / MotleyFool.com |
| Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target t... Jun 18 / Benzinga | Is This Hurting Healthcare Company Priced for a Recovery? Jun 13 / MotleyFool.com |
| Simcere Ties Up with Bristol-Myers - Analyst Blog Jun 17 / Zacks.com | 5 Leading Women in Health Care Jun 12 / MotleyFool.com |
| Label Expansion for Astellas Drug - Analyst Blog Jun 17 / Zacks.com | Undervalued Teva Must Enter New Markets Jun 12 / MotleyFool.com |
| $2.15B Settlement for Pfizer's Protonix - Analyst Blog Jun 13 / Zacks.com | Which Generic Drugmaker Is Your Best Buy Today? Jun 06 / MotleyFool.com |
| Actavis-Medicines360 Ink Partnership - Analyst Blog Jun 13 / Zacks.com | Actavis: The latest Fortune 500 company to "leave" the U.S. for tax reasons May 21 / Fortune |